Refine by
Preclinical Modeling Articles & Analysis: This-Month
1 articles found
A 2026 study of human and animal models identifies concurrent inhibition of the transcription regulators ID1 and ID3 as a potential therapeutic approach, given their upregulation in fibroblasts from diseased tissue.Dual targeting of ID1 and ID3Single-agent inhibition is insufficient because ID1 and ID3 compensate for each other; simultaneous inhibition is required to yield ...